DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Yanai H, Lichtenstein L, Assa A. et al.
Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab.

Clin Gastroenterol Hepatol 2015;
13: 522-530 e2

Yanai H, Lichtenstein L, Assa A. et al.
Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab.

Clin Gastroenterol Hepatol 2015;
13: 522-530 e2

Download Bibliographical Data

Search in:
Access: